Attenuated African swine fever viruses and the live vaccine candidates: a comprehensive review
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03199-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Jiaqi Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Ningxia University, Yinchuan, Ningxia, China. Hauptthemen laut MEDLINE: African Swine Fever Virus, Vaccines, Attenuated, African Swine Fever, Viral Vaccines. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Science and Technology Program Project, MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
The African swine fever virus (ASFV) is spreading worldwide and causing huge economic losses to the global pig industry. The ASFV genome is 170–193 kb in length, contains approximately 150 open reading frames, and encodes more than 200 proteins, most of which have unknown functions. Owing to the unique viral structure, replication strategy, large number of genes of unknown function, and complicated pathogenesis, vaccine development research is challenging. Several naturally attenuated ASFV isolates have been extensively investigated and many genetically manipulated, gene-deleted, and cell-adapted ASFVs have been reported. Currently, live attenuated viruses prepared from weakly virulent strains are an efficient method to provide effective protection in vaccinated pigs; however, these have seldom been widely approved for vaccine use, except in Vietnam. Herein, we summarize the attenuated isolates or vaccine candidates for live vaccines derived from different sources, including naturally mutated, attenuated, cell-adapted, and genetically modified recombinant ASFVs. This will help to understand the gene function and immunogenicity of attenuated live ASFV, as well as the shortcomings of these viruses as vaccine candidates, and provide clues to prepare live, efficient, and safe vaccines for African swine fever. IMPORTANCE Outbreaks of African swine fever (ASF) have caused devastating losses to the global pig industry. Pigs immunized with ASFV attenuated virus can resist the lethal challenge of a strongly virulent virus. Here, we summarize the virulence of naturally mutated, cell-adapted, and genetically recombinant ASFV for pigs, and the protective effect after facing an attack challenge. We also analyze the advantages and disadvantages of ASFV attenuated viruses as vaccine candidates to provide clues for the preparation of efficient and safe live African swine fever vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Ningxia University, Yinchuan, Ningxia, China.
- Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Key Laboratory of Prevention & Control for African Swine Fever and Other Major Pig Diseases, Ministry of Agriculture and Rural Affairs Changchun, Changchun, Jilin, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Förderung
- Guangdong Provincial Science and Technology Program Project
- MOST | National Key Research and Development Program of China (NKPs)
Zitieren
APA
Fan, J., Yu, H., Miao, F., Ke, J., & Hu, R. (2024). Attenuated African swine fever viruses and the live vaccine candidates: a comprehensive review. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03199-23
Vancouver
Fan J, Yu H, Miao F, Ke J, Hu R. Attenuated African swine fever viruses and the live vaccine candidates: a comprehensive review. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03199-23
BibTeX
@article{Fan2024,
author = {Fan, Jiaqi and Yu, Haisheng and Miao, Faming and Ke, Junnan and Hu, Rongliang},
title = {Attenuated African swine fever viruses and the live vaccine candidates: a comprehensive review},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03199-23}
}
EUVIMED